Skip to content

Pain reducing ability of Multiple Injection Costotransverse block vs peritubal local infiltration in patients undergoing percutaneous nephrolithotomy surgery: A Randomized Controlled trial.

Analgesic efficacy of Multiple injection Costotransverse block versus Local peritubal infiltration in patients undergoing percutaneous nephrolithotomy surgery: A Randomized Controlled trial.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2023/02/049871
Enrollment
68
Registered
2023-02-20
Start date
Unknown
Completion date
Unknown
Last updated
2023-03-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O- Medical and Surgical

Interventions

Intervention1: GROUP I: Multiple Injectate Costo-Transverse Foramen Block: The costotransverse block will be performed with the patient in the prone position, using a linear (13-6 MHz) or curvilinear

Sponsors

All India Institute of Medical Sciences
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients of ASA I - II aged between 18 & 65 years scheduled to undergo elective percutaneous nephrolithotomy surgery for renal and upper ureteric stone under general anesthesia

Exclusion criteria

Exclusion criteria: 1. Patientsâ?? refusal 2. ASA III OR IV 3. Allergy to any of the study drugs 4. Contraindications to regional technique e.g., allergy to local anaesthetic drugs, infection around site of block, any coagulation disorder, sepsis 5. History of analgesic dependence (long term use) and opiate tolerance 6. Contraindications to morphine e.g., local infection (administration site), systemic infection, coagulopathy, raised intracranial pressure, metastatic disease of the vertebral column, sleep apnea syndrome 7. Epilepsy and psychiatric disturbances 8. Conversion to open.

Design outcomes

Primary

MeasureTime frame
Total analgesic requirements (cumulative morphine consumption in 24 hours).Timepoint: from the end of surgery up to 24 hours in the post operative period.

Secondary

MeasureTime frame
11-point NRS scores at rest and at movement in postoperative period at the time interval of 2 hours, 4 hours, 6 hours,12 hours and 24 hours.Timepoint: from the end of surgery up to 24 hours in the post operative period.;Adverse events in 24 hoursTimepoint: from the end of surgery up to 24 hours in the post operative period.;Analgesic requirement at the end of 2 hours, 4 hours, 6 hours, 12 hours and 24 hoursTimepoint: from the end of surgery up to 24 hours in the post operative period.;Duration of analgesia (time for the first analgesia injection in postoperative period).Timepoint: from the end of surgery up to 24 hours in the post operative period.;Patient Satisfaction Score.Timepoint: from the end of surgery up to 24 hours in the post operative period.

Countries

India

Contacts

Public ContactDebesh Bhoi

All India Institute of Medical Sciences

debeshbhoi@gmail.com7042129428

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026